Inogen Welcomes Three New Executive Team Members

Inogen Inc. has appointed three new senior managers to help accelerate the company’s next phase of growth. Joining the core leadership group are Jason Richardson, chief financial officer (CFO); Dominic Hulton, chief marketing officer; and Corey Moritz, vice president, U.S. Business to Business sales.

Richardson succeeds Michael Bourque, who stepped down from his CFO role and is serving in an advisory capacity until June 30 to ensure a smooth transition. “It has been a privilege to be a part of the Inogen team, and I am proud of all we have accomplished together,” Bourque stated. “I am confident the finance organization is well positioned for continued success, and I am committed to support the transition to Jason.”

Richardson joins Inogen from Baxter International Inc., where he most recently served as CFO and vice president of the Healthcare Systems and Technologies segment, a $3 billion publicly reported business. He played a central role in Baxter’s integration of Hillrom, driving growth initiatives and improved operating performance. Before Baxter acquired Hillrom, Richardson worked in various senior finance leadership roles at Hillrom, including overseeing its Respiratory Care franchise, a durable medical equipment (DME) business focused on cystic fibrosis, bronchiectasis, and other respiratory diseases.

“We are pleased to welcome Jason as Inogen’s next chief financial officer,” Inogen President/CEO Kevin Smith said. “Jason’s deep expertise in finance and operations across the medical device and healthcare industries will be instrumental as we focus on delivering respiratory solutions to patients around the world and driving sustainable growth. On behalf of the Inogen team, I thank Mike for his many contributions to Inogen over the past two years. He played a key role in returning the company to positive adjusted EBITDA for the first time in four years and strengthening our foundation as we seek to capture significant market opportunities ahead. We are grateful for his service and expect to benefit from his support during the transition period.”

“I am honored to join Inogen and look forward to working closely with the board and management team to execute our strategy and deliver sustainable long-term value,” Richardson commented. “I am grateful that Mike is available to support a seamless transition.”

Hulton is a globally experienced commercial leader with more than 20 years of experience driving growth, expanding markets, and leading organizational transformation in medical technology. Hulton spent the last 11 years at Insulet Corporation, where he served as vice president of International Marketing and Sales Excellence. In that role, he led global product launches, built cross-functional teams and scaled commercial operations.

“Dominic’s experience is highly aligned with Inogen’s focus on strengthening our global brand, deepening customer engagement and enhancing commercial execution. We are thrilled to have him join our leadership team in the newly established chief marketing officer role,” Smith said. “As we continue to advance our innovation pipeline, including our goal of launching at least one new product per year, we expect Dominic’s strong track record of bringing products to market across geographies to help accelerate our growth and brand reach.”

“I look forward to joining the Inogen team and leading its marketing function at a pivotal moment for the company,” Hulton stated. “There is significant opportunity to expand Inogen’s global brand awareness and customer engagement, and I’m excited to play a role in shaping the company’s next phase of growth.”

Moritz is a healthcare executive with more than two decades of experience driving commercial transformation, revenue growth, and scalable expansion across medical devices, respiratory care, and health services organizations. He has successfully built six sales forces while delivering sustained growth, margin expansion, and strong commercial infrastructure. He previously served as chief commercial officer of Rhythm Healthcare, where he had a strong track record of driving significant revenue growth across multiple years.

“Corey is a strong addition to the Inogen team. He brings deep relationships across the U.S. HME and distributor sales channel and a proven track record of building and scaling high-performing sales teams,” Smith concluded. “His experience around improving commercial execution and sustained growth will support Inogen’s efforts to expand our presence across our growing product portfolio.”

“Since joining Inogen, I have been getting fully up to speed with the company’s commercial initiatives and believe we are well positioned to expand our reach across the U.S. business-to-business sales channel, build on our strong relationships and optimize our execution,” Moritz commented.

Inogen Inc. is a global medical technology company offering respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing best-in-class respiratory therapy devices that deliver care to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to distribute its respiratory therapy products.